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Abstract
Objectives: The aim of the study was to investigate the association between activity of ankylosing 
spondylitis (AS) and decrease in quality of life as well as productivity loss of affected patients in 
a specified group of patients in the Polish setting.
Material and methods: An questionnaire survey was conducted using the Bath Ankylosing Spondy-
litis Disease Activity Index (BASDAI) to assess disease activity, as well as the Work Productivity and 
Activity Impairment Questionnaires to assess productivity loss; quality of life was presented as utility 
calculated using the EuroQol 5 questionnaire and also measured on a visual analogue scale (VAS). 
Indirect costs were assessed with the human capital approach implying gross domestic product per 
capita or gross value added per worker in Poland in 2014 and were expressed in Polish zlotys (PLN) as 
well as in euros. Correlation was presented using Spearman’s rank correlation coefficient.
Results: We performed our analysis based on 78 full questionnaires collected. A mean BASDAI score 
of 5.91 in the analysed group of patients was detected and mean utility of 0.5135 was observed. Aver-
age quality of life measured on the visual analogue scale was 46.55. Mean number of days off work 
was 45.26 days per year and mean on-the-job productivity loss was 49.29%. Average annual indirect 
costs per patient were €4241 (17 686 PLN) calculated using gross domestic product and €10 172 
(42 417 PLN) estimated using gross value added. Total productivity loss was significantly correlated 
with disease activity (strong correlation of 0.6005) and utility (moderate correlation of –0.3698).
Conclusions: Ankylosing spondylitis causes a great decrease in quality of life as well as patients’ 
productivity loss associated with both absenteeism and presenteeism. The greater the disease ac-
tivity is, the lower is the utility, the lower is the quality of life measured on the VAS, and the greater 
are the total annual indirect costs. Total indirect costs were negatively correlated with utility; al-
though the association was moderate, it was significant.
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Introduction
Ankylosing spondylitis (AS) is an autoimmune rheu-
matic disease, which mainly affects the joints of the 
spine but may also affect peripheral joints. The domi-
nant symptom of AS is inflammatory back pain, which 
may be associated with ongoing aseptic inflammation 
of the intervertebral discs and ossification of spine lig-
aments with syndesmophytes formation, which leads 
to reduced spine mobility. The described changes cause 
functional impairment and great deterioration in quality 
of life. All pathological changes in the course of AS lead 
to disturbances related to the patient’s activity in the 
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labour market (loss of productivity). The prevalence of 
AS is between 0.1% and 1.4%, and it is more often diag-
nosed among men [1]. A recent study in Poland report-
ed average prevalence around 7.48 for 10,000 persons; 
from 6.15 for female to 8.91 for male gender (based on 
data from the National Health Fund) [2]. As the disease 
occurs mostly in young people, it causes a long-lasting 
decrease in productivity.
People affected with AS require lifelong treatment, 
generating great direct costs (cost of treatment, reim-
bursed drugs, etc.) to the national health insurance sys-
tem [2]. Also the value of lost productivity is an indirect 
cost – not due to incurred expenses, but due to the lack 
of work caused by the disease. A validated and simple 
diagnostic test that allows for measuring the disease 
activity in AS is the Bath Ankylosing Spondylitis Disease 
Activity Index (BASDAI) [3], while quality of life among 
patients with AS can be measured using the Euroqol 
questionnaire (EuroQol 5) [4]. 
BASDAI is a gold standard in AS activity assessment 
which takes into account five major symptoms of the 
disease: tiredness, spinal pain, joint pain (arthralgia), en-
thesitis (pain from areas of localized tenderness due to 
inflammation) and morning stiffness. For each domain 
patients report extent of a health problem – the higher 
the value, the greater the problem (pain, tiredness, etc.). 
Data are summarized as the BASDAI score, which can 
be obtained with the standardised on-line calculator [3].
EuroQol 5 is a standardized instrument for use as 
a measure of one of the most important health out-
comes – quality of life. It takes into account five of 
the most important aspects of life: mobility, self-care, 
housekeeping activities, pain and anxiety. For each do-
main the patient can report no problems – represented 
by number 1; some problems – represented by number 2; 
or a lot of problems – represented by number 3. Combin-
ing answers from all five domains, a quality of life state 
is created; e.g., “1, 3, 2, 2, 2” quality of life state repre-
sents no problems with mobility, a lot of problems with 
self-care and some problems concerning the remaining 
three domains. Data obtained using EuroQol 5 can be 
presented as the health state combined from all do-
mains or can be converted into utility using population 
tariffs. The EuroQol 5 questionnaire also allows patients 
to report their quality of life using a visual analogue 
scale (VAS) with which patients provide a subjective as-
sessment of quality of life [4].
The indirect costs that follow AS are associated with 
absence from work (absenteeism) and a decrease in the 
efficiency of work done by the patient (presenteeism). 
These two types of indirect costs express the extent of 
productivity losses. Absenteeism refers to the number 
of days on sick leave, periods of unemployment caused 
by disease, and early leaving of the labour market due 
to sickness (e.g. early retirement or early death). Leav-
ing the labour market due to early death is calculated 
quite rarely in the case of inflammatory diseases of the 
axial skeleton because of the long life expectancy, al-
though in some cases patients can suffer from infec-
tion, followed by malignancies and cardiovascular com-
plications which could lead to death [1, 5]. Presenteeism 
refers to a situation when a sick person is present at 
work but his or her productivity is lower than average 
due to the disease. Productivity losses due to lower effi-
ciency at work have been studied since the early 1990s, 
but this factor is commonly omitted in the indirect cost 
studies due to difficulties in estimation of the cost of 
lost productivity [6, 7].
Both absenteeism and presenteeism data were ob-
tained in a questionnaire survey with the Work Produc-
tivity and Activity Impairment Questionnaire (WPAIQ), 
which is a well-validated instrument to measure impair-
ments in work and activities and is a standard analytic 
tool commonly used to assess absenteeism and presen-
teeism in a number of diseases.
Each category of indirect costs (absenteeism, pre-
senteeism) can be calculated using two methods: the 
Human Capital Approach and the Friction Cost Ap-
proach. The Human Capital Approach (HCA) converts 
the gross income which will not be obtained in the fu-
ture due to disease into real costs from a social perspec-
tive; hence it assumes that the decrease in productivity 
is permanent (irreplaceable). The Friction Cost Approach 
(FCA) takes into account productivity losses until a new 
person is employed as a substitute for the sick one.
The aim of the study was to investigate the associ-
ation between activity of AS and decrease in quality of 
life as well as productivity loss of AS patients in a Polish 
setting.
Material and methods
A questionnaire survey was performed to collect 
data on disease activity, the quality of life of the popu-
lation assessed, as well as productivity loss. Volunteers 
with AS from the whole country were recruited through 
the Polish Society of Ankylosing Spondylitis [8]. We used 
the Bath Ankylosing Spondylitis Disease Activity Index 
(BASDAI) and paper EuroQol 5 questionnaires with 
a visual analogue scale (VAS) to obtain data on disease 
activity and patients’ quality of life. EuroQol 5 was used 
because it allows for validated conversion into utilities 
using the European population and is a standard analyt-
ic tool to assess the activity of the disease used world-
wide [9, 10]. Subjective general activity of AS, subjective 
tiredness and subjective pain caused by the disease 
were measured using the VAS. 
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The human capital approach was used to estimate 
indirect costs due to absenteeism and presenteeism. 
Two macroeconomic indicators for Poland were consid-
ered: gross domestic product per capita (GDP, equalled 
€10 774 or 44 928 PLN) and gross value added (GVA, 
equalled €25 838 or 107 744 PLN) per worker, presented 
in 2014 prices in euro (exchange rate used was 1 euro 
= 4.17 PLN) with a correction factor of 0.65 [11] (The 
conventional mean value of output elasticity of labour 
is 0.65 according to the Cobb-Douglas function of pro-
duction. This approach is suggested by the European 
Commission because increasing the amount of a single 
factor of production, with all other factors of production 
held constant, results in a decrease in the marginal out-
put of production) [12]. Gross domestic product per cap-
ita is a commonly used measurement for determining 
a country’s economic development. Its weakness is that 
it considers not only employees but also people who are 
economically inactive, such as children and retirees. The 
gross value added per worker reflects the true economic 
development in areas of production. It was expressed as 
value per worker and omits economically inactive peo-
ple. Because the gross value added represents the pro-
ductivity of a country in all economic sectors, the gross 
value added per worker is the best measurement for 
examining the decrease in human capital due to illness.
Continuous variables were summarised using means 
and standard deviations or median with the first and 
the third quartile. Nominal variables were summarized 
using counts and percentages. Spearman’s correlation 
was used to present the association between the dis-
ease activity, the quality of life as well as absenteeism 
and presenteeism. P-values less than 0.05 indicated 
statistical significance. Additionally, data on disease 
activity, patients’ quality of life and generated indirect 
costs were presented in scatterplots. Absenteeism was 
presented as the number of days missed from work per 
year, while presenteeism was shown as the percent-
age of on-the-job productivity decreased by ankylos-
ing spondylitis. Statistical analyses were performed in 
R 3.1.3 [13] and Microsoft Excel.
Results
We obtained 83 questionnaires, of which five lacked 
any data, giving a total of 78 questionnaires of patients 
aged from 19 to 60 years old. Basic characteristics of the 
population are presented in Table I.
All patients provided data on disease activity with 
the BASDAI questionnaire. Data reported by the patients 
are presented in Table II.
Based on those values the mean BASDAI score of 
5.91 (SD: 1.72) was evaluated. The minimum value of 
BASDAI score was 1.2, and the maximum observed value 
was as high as 8.8 points, which indicates active disease.
Mean subjective general activity of AS assessed 
using VAS was reported as 61.45 (SD: 20.77) and was 
highly correlated with BASDAI score (0.7582; p-value 
< 0.0001). Similar results were observed for subjec-
tive general tiredness caused by AS (assessed using 
VAS): mean value of 67.73 (SD: 20.77); correlation with 
BASDAI score of 0.7414 (p-value < 0.0001) and subjective 
Table I. Basic characteristics of patients included in the study
Characteristic Value for sample Value for population [11]
Age [years] 33.5 (28.75–42.25)* 40.16***
Male 38 (48.72%) 48.39%
Disease duration [years] from onset 12.28 (SD: 10.17)** –
Highest educational degree
elementary school 0 (0%) 18%
high school 23 (29.49%) 33%
undergraduate 7 (8.97%) 35%
graduate bachelor’s degree 12 (15.39%) 14%
graduate master’s degree or higher 36 (46.15%)
Place of living
city 61 (79.22%) 60.34%
village 16 (20.78%) 39.66%
Household members 3 (2–4)* 2.73***
*Median with the first and the third quartile; **Mean with standard deviation; ***Mean
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general pain caused by AS (assessed using VAS): 66.97 
(SD: 20.33); correlation with BASDAI score of 0.8090 
(p-value < 0.0001).
Data on productivity were collected for 73 patients, 
of which 58 (79.45%) are currently working. Among all 
working patients, 47 (81.03%) are on a full-time job con-
tract. Eight patients reported that their unemployment is 
due to AS (57.14% of unemployed patients). Duration of 
AS-related unemployment varied from less than a year 
to 23 years, with median duration of 5 years (the first 
and the third quartiles were 1.25 and 12.25, respectively).
Patients reported between 0 and 7 days off work 
during a week before filling the questionnaire, with 
a mean value of 0.87 (SD: 1.95) days per week or 45.26 
(SD: 101.54) days per year.
The relationship between absenteeism and disease 
activity (moderate correlation of 0.3145 with p-value of 
0.0231, which indicates statistical significance) is pre-
sented in Figure 1.
Most people reported a lack of days off work due to 
the disease, but generally there was revealed a signifi-
cant association with disease activity. All of the patients 
who reported at least one day off work had disease ac-
tivity, measured with the BASDAI score, greater than 5.
Average on-the-job productivity loss was 49.29% 
(23.96%), which represents the extent of presenteeism. 
The minimal reported value was 10% and the maximal 
value was 90%. Data are presented for 56 working AS 
patients; two working patients did not provide data on 
on-the-job productivity loss.
The relationship between presenteeism and disease 
activity (strong correlation of 0.6964 with p-value less 
than 0.0001, which indicates statistical significance) is 
presented in Figure 2. Loss of on-the-job productivity was 
positively correlated with disease activity. One patient 
reported high disease activity (7.2 on 10-point BASDAI 
scale) but only 10% of on-the-job decrease in productivity.
Data collected made it possible to assess annual 
indirect costs caused by both absenteeism and presen-
teeism generated by AS. Using gross domestic product 
(GDP) per capita we calculated indirect costs of absen-
teeism of €868 (SD: €1947); 3619 PLN (SD: 8118 PLN), 
presenteeism of €3452 (SD: €1678); 14393 PLN (SD: 
6996 PLN) and total indirect costs of €4241 (SD: €2829); 
17 686 PLN (SD: 11 799). Taking into account gross val-
ue added (GVA) per worker those costs were as fol-
lows: €2081 (SD: €4669); 8679 PLN (SD: 19 470 PLN), 
€8277 (SD: €4024); 34 516 PLN (SD: 16 778 PLN) and 
Table II. BASDAI characteristics
Characteristic Value*
fatigue/tiredness 7 (6–8)
neck, back or hip pain 7 (6–8)
pain/swelling in joints other than neck, back or hips 5 (3–7)
discomfort from areas tender to touch or pressure 6 (4–8)
discomfort from the time you wake up 7 (5–8)
morning stiffness duration 3 (2–5)**
*Median with the first and the third quartile; **Five is maximum 
possible value representing more than two hours of morning 
stiffness
Fig. 1. Relationship between absenteeism and disease activity. Total annual indirect cost per patient was 
€4241 (17 686 PLN) calculated using GDP and €10 172 (42 417 PLN) calculated using GVA.
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€10 172 (SD: €6786); 42 417 PLN (SD: 28 298 PLN) re-
spectively.
As a sensitivity analysis results without a correction 
factor (marginal productivity of labour) are also present-
ed. Total annual indirect costs per patient were €6525 
(SD: €4353); 27 209 PLN (SD: 18 152 PLN) and €15 649 
(SD: €10 440); 65 256 PLN (SD: 43 535 PLN) calculated 
using GDP and GVA, respectively.
The relationship between indirect costs calculated 
using GDP and disease activity (strong correlation of 
0.6005 with p-value less than 0.0001, which indicates 
statistical significance) is presented in Figure 3. The cor-
relation of disease activity with indirect costs calculated 
using GVA is the same.
Data on quality of life were also reported by a great 
majority (92%) of respondents.
Fig. 2. Relationship between presenteeism and disease activity.
Fig. 3. Relationship between total indirect costs calculated using GDP and disease activity. Total annual 
indirect cost per patient was €4241 (17 686 PLN) calculated using GDP.
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Based on data from Table III the health states were 
created. The most common state was “2, 2, 2, 2, 2” re-
ported by 20 (26.32%) patients, followed by “2, 1, 2, 2, 2” 
reported by 11 (14.47%) patients. The highest (worse) 
state observed was “2, 2, 3, 3, 2” and occurred in 1 pa-
tient (1.32%).
Based on these data the utility was calculated us-
ing the European tariff [10]. Mean utility equalled 0.5135 
(SD: 0.1912), the lowest calculated value was 0.1213, and 
the highest was 1. Additionally, patients reported their 
quality of life using the VAS. The mean VAS score was 
46.55 (SD: 24.21). Both utility and VAS were significantly 
(strong correlation of –0.6206 and –0.6082, respectively, 
with p-value less than 0.0001, which represents statisti-
cal significance) correlated with BASDAI score.
Patients’ quality of life expressed in the form of util-
ity was also correlated with presenteeism (correlation 
of –0.4109; p-value of 0.0018, which indicates statistical 
significance). In general, utility showed a negative mod-
erate but significant correlation with total indirect costs 
(correlation of –0.3698; p-value of 0.0076). Different re-
sults were observed for quality of life measured on the 
VAS, which was correlated significantly with extent of 
on-the-job loss in productivity (moderate correlation of 
–0.3907; p-value of 0.0038, which represents statistical 
significance). Presenteeism was significantly correlated 
with both utility and quality of life measured on the VAS. 
However, the general conclusion emerges that higher 
quality of life is associated with lower indirect costs.
Discussion
Ankylosing spondylitis causes a great decrease in 
quality of life. The greater the disease activity is, the low-
er is the quality of life, and this association was signifi-
cant for both utility and VAS. Moreover, our study proved 
that the greater the disease activity was, the greater 
were the annual indirect costs, and this association was 
strongly significant for presenteeism and less apparent 
for absenteeism.
Sliwczynski et al. [2] assessed the prevalence of an-
kylosing spondylitis (AS) in Poland and the costs gener-
ated by AS patients in the system of public health care. 
The database of the national payer (National Health 
Fund; NHF) was analysed to gather data on direct costs 
of therapy. In the years 2008–2013, from 28,800 to 
32,800 persons diagnosed with AS as the main or co-
existing diagnosis were registered in the NHF database. 
The healthcare expenses related to AS financed by the 
NHF increased from 13,200 million PLN (3.16 million 
euro) in 2008 to 72,600 million PLN (17,400 million euro) 
in 2013, so a significant increase in the burden of the 
disease (in terms of direct costs) was revealed [2].
Ankylosing spondylitis is a disease which occurs 
mainly in a population of young people (mostly middle 
aged men), contributing to a significant reduction of 
social and economic activity, and therefore reduces pro-
ductivity as well as quality of life of the patients, which 
is particularly severe for the whole society. 
The aim of our analysis was to acquire new knowl-
edge on the indirect costs and quality of life of AS pa-
tients, which constitute an increasingly important social 
problem. According to our knowledge, this is the first 
and the only study referring to utility measurement as 
well as indirect cost assessment in a group of Polish pa-
tients with AS. The methodology used as well as the re-
sults provided novel data filling in the information gap. 
Some studies have focused on the assessment of lost 
productivity due to absence from work (absenteeism), 
ignoring issues related to reduced productivity at work 
during the course of the disease (presenteeism). Our 
project involves the assessment of the costs in both as-
pects based on our own survey questionnaire, to let us 
know the real costs they generate in affected patients. 
On the other hand, the results of our study due to some 
limitations should be interpreted cautiously and are pre-
liminary, providing a good basis for further, more sophis-
ticated studies of this topic. 
A major limitation is due to recruitment of patients. 
The sample size was quite small and the methods of 
Table III. Number of patients reporting lack of problems, some problems or a lot of problems in specific life domains 
took into consideration in EuroQol 5 questionnaire
Life domain Problems reported with specific life domains
No Some A lot
Mobility 17 (22.37%) 59 (77.63%) 0 (0%)
Self-care 37 (48.68%) 39 (51.31%) 0 (0%)
Usual activities 15 (19.74%) 58 (76.31%) 3 (3.95%)
Pain 4 (5.26%) 59 (77.63%) 13 (17.11%)
Anxiety 12 (15.79%) 57 (75%) 7 (9.21%)
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respondents’ inclusion without randomised allocation 
gave results that are not fully representative for the 
whole AS population. In the analysed group of patients 
we found a slight over-representation of females, where-
as according to current literature males represent a ma-
jority of the population. We also recorded a high pro-
portion of individuals with higher education, which can 
influence labour market activity and probably influenced 
our results. Patients were enrolled from the whole coun-
try, but data on patients’ domicile were not collected.
In 2011 in the Polish population indirect cost as-
sessment was performed for patients with rheumatoid 
arthritis (RA). This questionnaire study was conducted 
on 814 ambulatory patients of working age. The study 
revealed that patients suffering from RA incurred 
29 727 PLN (7128 euro) in indirect costs annually, of 
which 12 922 PLN (3098 euro) were costs of absenteeism 
and 16 498 PLN (3956 euro) were costs of presenteeism. 
Researchers also used the WPAI questionnaire and GDP 
per worker methodology [14]. Although a large group in-
volved only ambulatory patients, assessment could have 
significantly influenced the results of this study. 
In order to compare our results with other elabora-
tions, we performed a review of medical databases. We 
discovered only two studies considering both absentee-
ism and presenteeism in an AS population, but none of 
them was conducted in Poland. Rafia et al. [15] reported 
3-month indirect cost per patient associated with ab-
senteeism equal to £38.61 and associated with presen-
teeism equal to £531.83. This is in agreement with our 
results showing that presenteeism was responsible for 
almost 80% of total indirect costs, whereas 93% was 
reported by Rafia et al. [15]. We discovered that presen-
teeism was responsible for around 91% of total costs.
Boonen et al. [16] described the influence of ankylos-
ing spondylitis on sick leave, presenteeism and unpaid 
work restrictions and to estimate related productivity 
costs. The annual production costs for the total group 
of 142 patients were 1451 euro (95% CI: 425–2742) per 
patient for sick leave (absenteeism) and 967 euro (95% 
CI: 503–1496) to compensate for hours worked inef-
ficiently while at work (presenteeism) and 1930 euro 
(95% CI: 1404–2471) to substitute loss of unpaid work 
production.
In 2009, National Ankylosing Spondylitis Society 
(NASS) published a survey of their members on working 
with AS in response to their expressed concerns about 
employment. NASS distributed a questionnaire to 1000 
members, receiving 324 responses from people with 
a current diagnosis of AS. 
The study revealed that the disease had an impact 
on productivity of patients, whereas effective treatment 
made a significant difference to being able to remain in 
work. In addition, people with more severe AS reported 
a greater impact on their working lives, and those with 
higher disease activity were twice as likely to report that 
their working life had been affected. Sixty-one percent 
were concerned about the impact of the deterioration 
of their condition on their job or employment prospects, 
and 30% had concerns about discrimination because 
of their AS, from employers or colleagues. Only 12% re-
ported that AS had made no significant impact on their 
working lives, whilst one-third reported that they were 
able to perform fewer physical or manual tasks at work 
than before the onset of AS [17].
Conclusions
Ankylosing spondylitis imposes a substantial per-
sonal burden and influences the ability to work. The 
observation concerning the influence of the disease 
on AS patients’ functional abilities requires special at-
tention in future studies on ankylosing spondylitis. AS 
generates huge indirect costs and decreases patients’ 
quality of life. There is a need for further studies with 
a fully representative population of patients for better 
understanding of the relation with indirect costs gener-
ated and disease activity.
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